Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type.

Microsatellite instability (MSI) and deficiency of mismatch repair (dMMR) are key markers for predicting the response of immune checkpoint inhibitors (ICIs) and screening for Lynch syndrome (LS). This study examined the incidences of and factors associated with the concordance of MSI and MMR in human cancers. A total of 518 formalin-fixed cancer tissues were analyzed for MSI and MMR immunohistochemistry (IHC). MSI was analyzed by a PCR-based method using Promega markers. Concordance with MMR expression and factors associated with concordance were analyzed. In 2 colorectal cancer samples, MMR IHC failed due to inadequate staining conditions. In the remaining 516 cancers, a high level of MSI (MSI-H) was identified in 113 cases, and dMMR was identified in 112. The concordance of MSI and MMR IHC was 98.3%. Only 9 cases (4 pancreatobiliary, 3 colorectal, and 2 endometrial cancers) were discordant. Of the 113 MSI-H cases, 4 (3.5%) were proficient MMR (pMMR); of the 403 microsatellite stability (MSS) cases, 5 (1.2%) were dMMR. The independent factors associated with MSI-H/dMMR included meeting Amsterdam II criteria, assay purpose, and sampling method. Multivariate analysis revealed that cancer type (gastrointestinal cancers or others) was associated with concordance of MSI and MMR IHC. Three LS cases with pancreatic or endometrial cancer demonstrated MSS and dMMR, and one biliary cancer showed MSI-H and pMMR. Discordance between MSI and MMR IHC occasionally occurs in pancreaticobiliary and endometrial cancers. When suspected, both MSI and MMR IHC should be done to judge the ICI indication and screen for LS.

[1]  H. Ono,et al.  Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses , 2022, BMC Cancer.

[2]  Shigeki Tanishima,et al.  Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors , 2021, Scientific Reports.

[3]  B. Bonanni,et al.  Microsatellite instability evaluation: which test to use for endometrial cancer? , 2021, Journal of Clinical Pathology.

[4]  K. Matsushita,et al.  Prediction of mismatch repair deficient biliary tract cancer: Role of morphological features and host immune response detected by routine hematoxylin‐eosin staining , 2021, Journal of hepato-biliary-pancreatic sciences.

[5]  A. Duval,et al.  Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer , 2021, ESMO open.

[6]  A. Ristimäki,et al.  Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer , 2021, Virchows Archiv.

[7]  K. Claes,et al.  Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer , 2021, Scientific Reports.

[8]  E. Oki,et al.  Real‐world data on microsatellite instability status in various unresectable or metastatic solid tumors , 2021, Cancer science.

[9]  K. Yamaguchi,et al.  Role of Tumor Mutation Burden Analysis in Detecting Lynch Syndrome in Precision Medicine: Analysis of 2,501 Japanese Cancer Patients , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[10]  M. Salto‐Tellez,et al.  Identifying mismatch repair‐deficient colon cancer: near‐perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population‐based series , 2020, Histopathology.

[11]  E. Petricoin,et al.  Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. , 2020, The Lancet. Oncology.

[12]  Xiao-Ding Liu,et al.  DNA Mismatch Repair Deficiency Detection in Colorectal Cancer by a New Microsatellite Instability Analysis System , 2020, Interdisciplinary Sciences: Computational Life Sciences.

[13]  P. Neven,et al.  Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D. , 2020, Gynecologic oncology.

[14]  Ahmet Zehir,et al.  Retained Mismatch Repair Protein Expression Occurs in Approximately 6% of Microsatellite Instability-High Cancers and is Associated with Missense Mutations in Mismatch Repair Genes. , 2019, Modern Pathology.

[15]  K. Yamaguchi,et al.  Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients , 2019, Cancer medicine.

[16]  A. Scarpa,et al.  ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  Aung Ko Win,et al.  Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database , 2019, Genetics in Medicine.

[18]  J. Lang,et al.  Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China , 2019, Cancer communications.

[19]  K. Yamaguchi,et al.  Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy , 2019, Cancer science.

[20]  Ahmet Zehir,et al.  Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Kamel‐Reid,et al.  Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation , 2018, The journal of pathology. Clinical research.

[22]  T. Yamanaka,et al.  Utility of the quasi‐monomorphic variation range in unresectable metastatic colorectal cancer patients , 2018, Cancer science.

[23]  Y. Miyagi,et al.  The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research: Standard operating procedures based on empirical analyses , 2018, Pathology international.

[24]  C. Iacobuzio-Donahue,et al.  Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations , 2018, Clinical Cancer Research.

[25]  Russell Bonneville,et al.  Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.

[26]  H. Morreau,et al.  Practical guidance for mismatch repair-deficiency testing in endometrial cancer , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  S. Ogino,et al.  Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. , 2017, The Journal of molecular diagnostics : JMD.

[28]  J. Kench,et al.  Hypermutation In Pancreatic Cancer. , 2017, Gastroenterology.

[29]  P. Devilee,et al.  Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome , 2016, Human mutation.

[30]  P. Park,et al.  A molecular portrait of microsatellite instability across multiple cancers , 2016, Nature Communications.

[31]  James R. Eshleman,et al.  Microsatellite Instability as a Biomarker for PD-1 Blockade , 2016, Clinical Cancer Research.

[32]  Alan Barkun,et al.  American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome. , 2015, Gastroenterology.

[33]  C. Decaestecker,et al.  Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis , 2015, British Journal of Cancer.

[34]  A. Talhouk,et al.  Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas. , 2015, Gynecologic oncology.

[35]  I. Bernstein,et al.  Challenges in the Identification of MSH6-Associated Colorectal Cancer: Rectal Location, Less Typical Histology, and a Subset With Retained Mismatch Repair Function , 2011, The American journal of surgical pathology.

[36]  J. Swensen,et al.  Avoidance of pseudogene interference in the detection of 3′ deletions in PMS2 , 2011, Human mutation.

[37]  J. Hopper,et al.  Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. , 2011, The Journal of molecular diagnostics : JMD.

[38]  R. Yantiss,et al.  Neoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal Carcinoma , 2010, The American journal of surgical pathology.

[39]  A. Gill,et al.  Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma , 2010, Pathology.

[40]  L. Rozek,et al.  Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. , 2010, Gastroenterology.

[41]  A. Sepulveda,et al.  Assessment of Microsatellite Instability in Very Small Microdissected Samples and in Tumor Samples that are Contaminated With Normal DNA , 2006, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[42]  M. Kloor,et al.  Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis. , 2005, The Journal of molecular diagnostics : JMD.

[43]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[44]  J. Faivre,et al.  Microsatellite instability and intratumoural heterogeneity in 100 right-sided sporadic colon carcinomas , 2002, British Journal of Cancer.

[45]  M. Loda,et al.  Evaluation of Microsatellite Instability and Updated Version Cited Articles Citing Articles E-mail Alerts Evaluation of Microsatellite Instability and Immunohistochemistry for the Prediction of Germ-line Msh2 and Mlh1 Mutations in Hereditary Nonpolyposis Colon Cancer Families , 2022 .

[46]  L. Albarello,et al.  Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences , 2000, Virchows Archiv.